A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings
- 20 August 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 26 (12), 1479-1491
- https://doi.org/10.1007/s11606-011-1825-3
Abstract
Medications are a cornerstone of the prevention and management of cardiovascular disease. Long-term medication adherence has been the subject of increasing attention in the developed world but has received little attention in resource-limited settings, where the burden of disease is particularly high and growing rapidly. To evaluate prevalence and predictors of non-adherence to cardiovascular medications in this context, we systematically reviewed the peer-reviewed literature. We performed an electronic search of Ovid Medline, Embase and International Pharmaceutical Abstracts from 1966 to August 2010 for studies that measured adherence to cardiovascular medications in the developing world. A DerSimonian-Laird random effects method was used to pool the adherence estimates across studies. Between-study heterogeneity was estimated with an I2 statistic and studies were stratified by disease group and the method by which adherence was assessed. Predictors of non-adherence were also examined. Our search identified 2,353 abstracts, of which 76 studies met our inclusion criteria. Overall adherence was 57.5% (95% confidence interval [CI] 52.3% to 62.7%; I2 0.98) and was consistent across study subgroups. Studies that assessed adherence with pill counts reported higher levels of adherence (62.1%, 95% CI 49.7% to 73.8%; I2 0.83) than those using self-report (54.6%, 95% CI 47.7% to 61.5%; I2 0.93). Adherence did not vary by geographic region, urban vs. rural settings, or the complexity of a patient’s medication regimen. The most common predictors of poor adherence included poor knowledge, negative perceptions about medication, side effects and high medication costs. Our study indicates that adherence to cardiovascular medication in resource-limited countries is sub-optimal and appears very similar to that observed in resource-rich countries. Efforts to improve adherence in resource-limited settings should be a priority given the burden of heart disease in this context, the central role of medications in their management, and the clinical and economic consequences of non-adherence.Keywords
This publication has 87 references indexed in Scilit:
- Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patientsPharmacoepidemiology and Drug Safety, 2008
- Medication Adherence After Myocardial Infarction: A Long Way Left To GoJournal of General Internal Medicine, 2008
- Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trialBMJ, 2007
- Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in NigeriaBMC Complementary and Alternative Medicine, 2007
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and FacilitatorsPLoS Medicine, 2006
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- What can patient health education coordinators learn from ten years of compliance research?Patient Education and Counseling, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986